DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE: Q) announced today
the pricing of an underwritten, secondary public offering of 9,000,000
shares of its common stock by certain of its existing stockholders,
including affiliates of TPG Global, LLC, CPP Investment Board Private
Holdings, Inc., investment funds associated with Bain Capital Investors,
LLC, and Leonard Green & Partners, L.P. (the “Selling Stockholders”) at
a price to the public of $95.25 per share. QuintilesIMS intends to
repurchase from the underwriter 4,000,000 shares.
QuintilesIMS is not offering any stock in this transaction and will not
receive any proceeds from the sale of the shares by the Selling
Stockholders in the offering. QuintilesIMS’s per-share purchase price
for the repurchased shares will be the same as the per-share purchase
price payable by the underwriter to the Selling Stockholders.
QuintilesIMS expects to fund the repurchase with cash on hand and
borrowings from its revolving credit facility.
Goldman Sachs & Co. LLC is acting as the sole underwriter for the
offering.
The offering, including the repurchase, is expected to close on
September 19, 2017, subject to customary closing conditions.
An automatic shelf registration statement (including a prospectus)
relating to the offering of common stock was filed with the Securities
and Exchange Commission (SEC) on May 24, 2017 and became effective upon
filing. Before you invest, you should read the registration statement,
prospectus, prospectus supplement and other documents QuintilesIMS has
made available with the SEC for information about QuintilesIMS and the
offering. You may obtain these documents free of charge by visiting
EDGAR on the SEC website at www.sec.gov.
Alternatively, copies of the prospectus and accompanying prospectus
supplement may be obtained from: Goldman Sachs & Co. LLC, Attn:
Prospectus Department, 200 West Street, New York, NY 10282, telephone:
(212) 902-1171, facsimile: 212-902-9316, e-mail: prospectus-ny@ny.email.gs.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there be any
sale of these securities in any state or other jurisdiction in which
such an offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or other jurisdiction.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated to
helping its clients improve their clinical, scientific and commercial
results. Formed through the merger of Quintiles Transnational and IMS
Health, QuintilesIMS’s approximately 50,000 employees conduct operations
in more than 100 countries. Companies seeking to improve real-world
patient outcomes through treatment innovations, care provision and
access can leverage QuintilesIMS’s broad range of healthcare
information, technology and service solutions to drive new insights and
approaches. QuintilesIMS provides solutions that span clinical to
commercial, bringing customers a unique opportunity to realize the full
potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS protects
individual privacy while managing information to drive healthcare
forward. These insights and execution capabilities help biotech, medical
device and pharmaceutical companies, medical researchers, government
agencies, payers and other healthcare stakeholders in the development
and approval of new therapies, and to identify unmet treatment needs and
understand the safety, effectiveness and value of pharmaceutical
products in improving overall health outcomes.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170914006528/en/
Source: Quintiles IMS Holdings, Inc.